Biodexa Pharmaceuticals (BDRX) Times Interest Earned (2013 - 2025)
Biodexa Pharmaceuticals (BDRX) posted Times Interest Earned of $29.75 for Q2 2025, down 65.48% sequentially from $86.18 in Q4 2024.
Biodexa Pharmaceuticals (BDRX) Times Interest Earned (2013 - 2025) Analysis & Trends
Biodexa Pharmaceuticals has reported Times Interest Earned for 12 years, with the latest figure at $29.75 in Q2 2025.
- Quarterly Times Interest Earned changed N/A year-over-year to $29.75 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $104.44 (changed N/A YoY) and the FY2025 annual result came in at $37.75, up 167.71% from the prior year.
- Times Interest Earned eased to $29.75 in Q2 2025 per BDRX's latest filing, from $86.18 in the prior quarter.
- Over five years, Times Interest Earned peaked at $192.91 in Q2 2023 and troughed at $20.73 in Q3 2021.
- A 5-year average of $95.02 and a median of $86.18 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2021 and 2022: Times Interest Earned plunged 97.51% in 2021, then jumped 659.34% in 2022.
- Over 5 years, Times Interest Earned stood at $20.73 in 2021, then jumped by 659.34% to $157.42 in 2022, then increased by 22.55% to $192.91 in 2023, then slumped by 55.32% to $86.18 in 2024, then slumped by 65.48% to $29.75 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered $29.75, $86.18, and $192.91 for Q2 2025, Q4 2024, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Biodexa Pharmaceuticals | 64,325.41 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 29.75 |
| Dec 31, 2024 | 86.18 |
| Jun 30, 2023 | 192.91 |
| Dec 31, 2022 | 157.42 |
| Sep 14, 2022 | 157.42 |
| Dec 31, 2021 | 20.73 |
| Sep 17, 2021 | 20.73 |
| Dec 31, 2020 | 53.46 |
| Sep 10, 2020 | 833.86 |
| Dec 31, 2019 | 116.68 |
| Dec 31, 2018 | 20.13 |
| Dec 31, 2016 | 174.57 |
| Dec 31, 2015 | 418.99 |
| Dec 31, 2014 | 60.17 |
| Dec 31, 2013 | 11.69 |